Özgür ÖZYILKAN, Fatih KÖSE, Melis PEHLİVANTÜRK, Ahmet SEZER

Hipodermokliz (Sürekli subkütanöz infüzyon): Onkoloji hastalarında etkili bir hidrasyon tedavisi (?)

Hipodermokliz (HDC) özellikle uzun süreli bakım gören hastalarda, intravenöz kateterizasyonun sağlanamadığı durumlarda başvurulabilecek güvenli, uygulanması kolay, hasta uyumunun yüksek olduğu bir yöntemdir. HDC subkütanöz yolla sıvı infüzyonunu sağlamada kullanılan bir yoldur. Klinik uygulamalarda hafif ve orta dereceli dehidratasyonun tedavisinde, subkütan yolla uygulanabilecek antibiyotik, morfin, karbamazepin gibi ilaçların replasmanında kullanılmaktadır. Yöntemin kolay uygulanabilir olması, hastanın hidrasyon ve ilaç veriminin kendi evinde veya bakım evinde devam etmesine olanak sağlamaktadır. Bu durum göz önünde bulundurulduğunda, HDC özellikle yaşlı populasyondaki mortalite ve morbidite ile yakından ilişkili olan dehidratasyonun önlenmesinde, intravenöz kateterizasyona güvenli bir alternatif oluşturmaktadır. Bu derlemede son yıllarda eski güncelliğini tekrar kazanmış olan HDC yönteminin tekniğini, endike ve kontrendike olduğu durumları, avantaj ve dezavantajlarını, istenmeyen etkilerini, HDC `nin hyaluranik asit ile birlikte uygulanmasını ve HDC’nin özellikle terminal dönemdeki hastalar açısından onkolojideki kullanım yerini açıklamayı amaçladık.

Hypodermoclysis (Continous subcutaneous infusion): An efficient hydration treatment for oncology patients (?)

Hypodermoclysis (HDC) is safe, easy to use, and comfortable way to deliver medication for the patients who have chronic illness and couldn’t use intravenous line. HDC can supply some intravenous hydration with subcutaneous route. In clinical practice, DHC can be used in the treatment of mild and moderate dehydration. Morphine, some kind of antibiotics, and carbamazepine can be applied via DHC safely. Moreover it can be performed easily; most of the medication and hydration treatment can be given in home care or nursing care settings. After all, HDC is a very safe method to prevent dehydration that can cause severe morbidity especially for older patients and it may be used as alternative method to intravenous catheterization for these purposes. Herein, we aim to discuss indication and contraindications, advantages and disadvantages, complications, application with hyaluronic acid of HDC and also its general usage for terminally ill cancer patients

PDF

___

1-Arinzon Z, Feldman J, Fidelman Z, et al. Hypodermoclysis (subcutaneous infusion) effective mode of treatment of dehydration in long-term care patients. Arch Gerontol Geriatr 2004;38(2):167-73.
2-Aangenendt-Siegers IP, Cools HJ. Cause of death in nursing homes. Ned Tijdschr Geneeskd 1992;136(41):2015-7.
3-Walsh G. Hypodermoclysis: an alternate method for rehydration in long-term care. J Infus Nurs 2005;28(2):123-9.
4-Sasson M, Shvartzman P. Hypodermoclysis: an alternative infusion technique. Am Fam Physician 2001;64(9):1575-8.
5-Mansfield S, Monaghan H, Hall J. Subcutaneous fluid administration and site maintanence. Nurs Stand 1998;13(12):56, 59-62.
6-Steiner N, Bruera E. Methods of hydration in palliative care patients. J Palliat Care 1998;14(2):6-13.
7- Thomas DR, Cote TR, Lawhorne L, et al. Understanding clinical dehydration and its treatment. J Am Med Dir Assoc 2008;9(5):292-301.
8-Dasgupta M, Binns MA, Rochon PA. Subcutaneous fluid infusion in a long-term care setting. J Am Geriatr Soc 2000;48(7):795-9.
9-Frisoli Junior A., de Paula AP., Feldman D., Nasri F. Subcutaneous hydration by hypodermoclysis. A practical and low cost treatment for elderly patients. Drugs Aging. 2000;16:313-9.
10-Day HB. The treatment of infantile diarrhoea by saline injections. Practitioner 1913;91:58-64.
11- Berger EY. Nutrition by hypodermoclysis. J Am Ger Society 1984;32:199-203.
12-Rogers L. A simple curative treatment of cholera. BMJ 1910;24:835- 839.
13-Gaisford W, Evans DG. Hyaluronidase in Paediatric therapy. Lancet 1949;2:505-7.
14-Israels S, Wylie K. The dangerous hypodermoclysis in infancy. Canad MAJ 1959;80:31-32.
15-Lipschitz S, Campbell AJ, Roberts MS et al. Subcutaneous fluid administration in elderly subjects: Alidation of an under-used technique. J Am Geriatr Soc 1991; 39: 6-9.
16-Remington R, Hultman T. Hypodermoclysis to treat dehydration:a review of the evidence. J Am Geriatr Soc 2007;55:2051-2055.
17-Hecter O. The clinical use of hyaluronidase in hypodermoclysis. J Pediatr 1947;30:645-656.
18-Constans T, Dutertre JP, Froge E. Hypodermoclysis in dehydrated elderly patients: Local effects with and without hyaluronidase. J Palliat Care 1991;7(2):10-2.
19-Ebo DG, Goosens S, Opspmer F, et all. Flow-assisted diagnosis of anaphylaxis to hyaluronidase. Allergy 2005;60:1333-1334.
20-Rosene D. Initial experiences with subcutaneous recombinant human hyaluronidase. J Palliative Medicine 2007;10(4):861-4.
21-Schen RJ, Singer-Edelstien M. Subcutaneous infusions in the elderly. J Am Geriatr Soc 1981;29:583-5.
22-O’Keefe ST, Lavan JN. Subcutaneous fluids in elderly hospital patients with cognitive impairment. Gerontolgy 1996;42:36-9.
23-Hypodermoclysis Working Group. Hypodermoclysis Guidelines on the technique. 1998, CP Pharmaceutical Ltd., Wrexham.
24-Turner T, Cassano AM. Subcutaneous dextrose for rehydration of elderly patients-an evidence based review. BMC Geriatrics 2004;4:2.
25-Jain S, Mansfield B, Wilcox MH. Subcutaneous fluid administration: better than the intravenous approach? J Hosp Infec 1999;41:269-72.
26-Bruera E, Legris MA, Kuehn N, Miller MJ. Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer. J Pain Symptom Manage 1990;5:218-20.
27-Bruera E, Brenneis C, Michaud M, et al. Use of the subcutaneous route fort he administration of narcotics in patients with cancer pain. Cancer 1988;62:407-411.
28-Fenske NA, Lober CW. Structural and functional changes of normal ageing skin. J Am Acad Dermatol 1986;15:571-85.
29-Dardaine V, Garrigue MA, rapin CH, Constans T. Metabolic and hormonal changes induced by hypodermoclysis of glucose saline solution in elderly patients.
30-Challiner YC, Jarret D, Haywood MJ, et al. A comparison of intravenousand subcutaneous hydration in elderly acute stroke patients. Postgrad Med J 1994;70:195-197.
31-Xiao H, Barber J, Campbell ES. Economic burden of dehydration among hospitalized elderly patients. Am J Health Syst Pharm 2004;61:2534-2540.
32-Lavy E, Ziv G, Shem Tov M, et al. Pharmacokinetics of clindamycin HCl administered intravenously , intramuscularly and subcutaneously to dogs. J Vet Pharmacol Ther 1999;22:1204-5.
33-Champoux N, Du Souich P, ravaoarinoro M, et al. Single dose pharmacokinetics of ampicillin and tobramycin administered by hypodermoclysis in young and older healthy volunteers. Br J Clin Pharmacol 1996;42:325-331.
34- Slesak G, Schnurle JW, Kinzel E, et al. Comparasion of subcutaneous and intravenous rehydration in geriatric patients:a randomized trial. J Am Geriatr Soc 2003;51:155-160.
35-Fainsinger RL, MacEachern T, Miller MJ, et al. The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage 1994;9(5):298-302.
36-Bruera E, Neumann CM, Pituskin E, et al. A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydration. Annals of Oncology 1999; 10:1255-1258.
37-Bruera E, de Stoutz N, Fainsinger RL, et al. Comparison of two different concentrations of hyaluronidase in patients receiving one-hour infusion of hypodermoclysis. J Pain Symptom Manage 1995;10:505- 509.
38-Razska WV, Kueser TK, Smith FR, Bass JW. The use hyaluronidase in the treatment of intravenous extravasation injuries. J Perinatol 1990;10:146-9.
39-Tully JL, Friedland GH, Baldini LM, Goldmann DA. Complications of intravenous therapy with steel needles and teflon catheters. A comparative study. Am J Med 1981;70:702-706.
40-Hussain NA, Warshaw G. Utility of clysis for hydration in nursing home residents. J Am Geriatr Soc 1996;44:969-73.
41-Yap LK, Tan SH, Koo WH. Hypodermoclysis or subcutaneous infusion revisited. Singapore Med J 2001;42:526-529.
42-Gluck SM. Hypodermoclysis revisited. JAMA 1982;248:1310-1311.
43-Shalini D, Eduardo B. Dehydration in cancer patients:to treat or not treat. J Support Oncol 2004;2:467-87.
44-Continuous subcutaneous access devices:standarts:nonvascular device. J Infus Nurs 2006;29:S68-S69.
45-Phillips PA, Rolls BJ, Ledingham JGG, Morton JJ. Reduced thirst after water deprivation in health elderly men. N Eng J Med 1984;311:753-59.
46-Bruera E, Maria P, Teresa S, et al. Proctolysis for hydration of terminally ill cancer patients. J Pain Symptom Manage 1998;15:216-19.
47-Robin L.F, Eduardo B. When to treat dehydration in a terminally ill patient? Support Care Cancer 1997;5:205-211.
48-Lanuke K, Fainsinger RL, DeMoissac. Hydration management at the end of life. J Palliat Med 2004;7:257-63.
49-Portenoy R. Continuous infusion of opioid drugs in the treatment of cancer pain: Guideline for use. J Pain Symptom Management 1986;1:223-228.
50-Martinez-Riquelme A, Rawlings J, Stephen M, et al. Selfadministration subcutaneous fluid infusion at home in the management of fluid depletion and hypomagnesemia in gastro-intestinal disease. Clinical Nutrition 2005;24:158-163.
51-Worobec G, Brown MK. Hypodermoclysis therapy in a chronic care hospital setting. J Gerontol Nurs 1997;23:23-28.
52-MacMillan K, Bruera E, Kuehn N, et al. A prospective comparasion study between a butterfly needle and a teflon cannula for subcutaneous narcotic administration. J Pain Symptom Manage 1994;9:82-84.
53-Herndon CM, Fike DS. Continuous infusion practices of United states hospices. J Pain Symptom Manage 2001;22:1027-34.
54-Moulin DE, Kreeft JH, Murray-Parsons N, Bouquillon Al. Comparison of continuous subcutaneous and intravenous hydromorphone infusion for management of cancer pain. Lancet 1991;337:465-8.
55-Nelson KA, Glare PA, Walsh D, Groh ES. A prospective, withinpatient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain. J Pain Symptom Manage 1997;13:262-7.